These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17124784)

  • 21. Hyposensitization.
    Saeed SA
    J Coll Physicians Surg Pak; 2005 Apr; 15(4):250. PubMed ID: 15912630
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical results from vaccination with recombinant grass pollen allergens.
    Jutel M; Cromwell O
    Clin Dev Immunol; 2006; 13(2-4):389-94. PubMed ID: 17162383
    [No Abstract]   [Full Text] [Related]  

  • 23. Specific immunotherapy--the induction of new IgE-specificities?
    van Hage-Hamsten M; Valenta R
    Allergy; 2002 May; 57(5):375-8. PubMed ID: 11972475
    [No Abstract]   [Full Text] [Related]  

  • 24. Pollen and inhalant allergy.
    Fountain DW
    Biologist (London); 2002 Feb; 49(1):5-9. PubMed ID: 11852278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Basis of specific desensitization].
    Vervloet D
    Allergol Immunopathol (Madr); 1981; Suppl 9():163-6. PubMed ID: 7349725
    [No Abstract]   [Full Text] [Related]  

  • 26. Specific immunotherapy, one century later.
    Passalacqua G; Bush RK
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):551-3. PubMed ID: 21971328
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
    González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
    J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergen-specific immunotherapy.
    Niederberger V
    Immunol Lett; 2009 Feb; 122(2):131-3. PubMed ID: 19100771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for using pollen cross-reactivity in formulating allergen immunotherapy.
    Weber RW
    J Allergy Clin Immunol; 2008 Jul; 122(1):219-21. PubMed ID: 18602577
    [No Abstract]   [Full Text] [Related]  

  • 30. [Recombinant allergens; allergy vaccine in the future?. Interview by Dr. Barbara Scholtissek].
    Valenta R
    Wien Med Wochenschr; 1999; 149(14-15):450-1. PubMed ID: 10584293
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy.
    Valenta R; Vrtala S; Focke-Tejkl M; Twardosz A; Swoboda I; Bugajska-Schretter A; Spitzauer S; Kraft D
    Clin Allergy Immunol; 2002; 16():495-517. PubMed ID: 11577556
    [No Abstract]   [Full Text] [Related]  

  • 32. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
    Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
    Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desensitization to lenograstim after a life- threatening reaction to filgrastim.
    Nuñez-Acevedo B; Rodríguez-Jiménez B; Domínguez-Ortega J; González-Montellano E; Ibáñez-Heras N; Enrech-Francés S
    J Investig Allergol Clin Immunol; 2015; 25(2):158-60. PubMed ID: 25997320
    [No Abstract]   [Full Text] [Related]  

  • 34. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
    Werfel T
    J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
    [No Abstract]   [Full Text] [Related]  

  • 35. Tree pollen allergens.
    Swoboda I; Twaroch T; Valenta R; Grote M
    Clin Allergy Immunol; 2008; 21():87-105. PubMed ID: 18828500
    [No Abstract]   [Full Text] [Related]  

  • 36. Weed pollen allergens.
    Mohapatra SS; Lockey RF; Polo F
    Clin Allergy Immunol; 2008; 21():127-39. PubMed ID: 18828502
    [No Abstract]   [Full Text] [Related]  

  • 37. Recombinant food allergens in the diagnosis of pollen-related food allergy.
    Ballmer-Weber BK; Wangorsch A; Scheurer S
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):192-6; discussion 197. PubMed ID: 15119039
    [No Abstract]   [Full Text] [Related]  

  • 38. Some highlights of the first century of immunotherapy.
    Nelson HS
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):417-21. PubMed ID: 22018612
    [No Abstract]   [Full Text] [Related]  

  • 39. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotherapy for food and latex allergy.
    Nowak-Wegrzyn A; Sicherer SH
    Clin Allergy Immunol; 2008; 21():429-46. PubMed ID: 18828521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.